Author

Si-On Park

Observed name: Si-on Park

Institutions: CHA Vaccine Institute (South Korea), CHA University

Observed institutions: Asan Medical Center, University of Ulsan, CHA Vaccine Institute (South Korea), CHA University

ORCID: 0000-0002-4098-9058

Observed ORCID: 0000-0002-4098-9058

OpenAlex ID: A5034394056

Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification

2021 · Bongkun Choi, Eun-Young Kim, et al. · Cells · 43

Interleukin-22 Mediates the Chemotactic Migration of Breast Cancer Cells and Macrophage Infiltration of the Bone Microenvironment by Potentiating S1P/SIPR Signaling

2020 · Eun-Young Kim, Bongkun Choi, et al. · Cells · 28

Sphingosine-1-phosphate hinders the osteogenic differentiation of dental pulp stem cells in association with AKT signaling pathways

2022 · Bongkun Choi, Ji-Eun Kim, et al. · International Journal of Oral Science · 19

L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic Cells

2023 · Yoonki Heo, Eunbyeol Ko, et al. · Cancers · 13

USP11 promotes colorectal cancer progression by stabilizing EGFR and TRAF6: a potential therapeutic target in EGFR- and TLR-driven tumorigenesis

2025 · Ji Hye Shin, Ji Young Kim, et al. · Cell Death and Disease · 7

Dysfunction in parkin aggravates inflammatory bone erosion by reinforcing osteoclast activity

2023 · Eun-Young Kim, Ji-Eun Kim, et al. · Cell & Bioscience · 5

AWP1 Restrains the Aggressive Behavior of Breast Cancer Cells Induced by TNF-α

2021 · Eun-Young Kim, Ji-Eun Kim, et al. · Frontiers in Oncology · 4

Works count: 7

Citation count: 119

H-index: 5

I10-index: 4